Menu Back to 5th-DIA-China-Drug-Discovery-Innovation-Conference

Overview

2019 will be DDI’s 5th Anniversary Conference and will be hosted in October in Shanghai, China, marking an important milestone and signifying the need for continuity in facilitating and exchanging vital information and discussing local challenges, technologies and services in a neutral environment.


Who should attend?

The DDI platform offers a unique opportunity for key stakeholders to come together and exchange expertise, experience and opinions, bringing together 600+ innovators and key thought leaders including:

  • Drug Discovery Scientists
  • Clinical Researchers
  • Regulatory Affairs Professionals
  • Business Developers
  • Investors
  • Project Managers
  • And More!

Program Chair

DDI_wangzaiqiDr. WANG Zaiqi
CEO, InxMed


Program Co-Chair

DDI_heruyi Dr. HE Ruyi
Adjunct Professor, Director of Academic Committee, Center for Regulatory Science, School of Medicine, Tsinghua University; Chief Medical Officer, SDIC Fund Management Co.

Steering Committee

DDI_luxianpingDr. LU Xianping
Chairman and CEO, Shenzhen Chipscreen Biosciences Co., Ltd.


DDI_wangzaiqiDr. WANG Zaiqi
CEO, InxMed


DDI_wangjingsongDr. WANG Jingsong
CEO, Harbour Biomed (HBM), China


DDI_taokangweiDr. TAO Weikang
CEO, Corp VP and CEO of R&D Centers
Jiangsu Hengrui Medicine Co., Ltd.


DDI_zhulihongMs. Carol ZHU
Senior Vice President and Managing Director, DIA China


DDI_heruyiDr. HE Ruyi
Adjunct Professor, Director of Academic Committee, Center for Regulatory Science, School of Medicine, Tsinghua University; Chief Medical Officer, SDIC Fund Management Co.


Program Committee

  • Wendy  Yan, MD, MBA
    Wendy Yan, MD, MBA Senior Vice President, Head of Regulatory Affairs
    BeiGene (Beijing) Co., Ltd., China
Load More

Contact us

Registration?

DIA China
86 10 57042659

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download